Karyopharm Therapeutics (KPTI) PT Lowered to $16 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts KPTI Hot Sheet
Price: $1.97 -2.96%
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Rating Summary:
11 Buy, 6 Hold, 1 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 18 | Down: 16 | New: 9
Join SI Premium – FREE
H.C. Wainwright analyst Edward White lowered the price target on Karyopharm Therapeutics (NASDAQ: KPTI) to $16.00 (from $18.00) while maintaining a Buy rating.
You May Also Be Interested In
- Karyopharm Therapeutics (KPTI) Misses Q2 EPS by $1.01, Beats on Revenue; Offers FY26 Revenue Guidance
- Galaxy Entertainment Group Ltd (27:HK) (GXYEF) PT Lowered to HK$43.60 at Macquarie
- Kikkoman (2801:JP) PT Raised to JPY2,000 at Nomura/Instinet
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
